Content area

Abstract

Vaccine hesitancy is the delay in acceptance or outright refusal of immunizations, which has evolved into a growing public health threat. In this article, we explore recent trends in vaccine hesitancy in the setting of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic, vaccine-specific variations, social media influence, and sociodemographic factors. During the coronavirus disease 2019 pandemic, the antivaccine movement gained increasing support and generated widespread conspiracy theories and mistrust. This highlighted the importance of enhancing communication between the health care field and general public. While the impact of antivaccine social media is widespread, physicians have also begun to use technology to spread factual information and increase vaccination uptake. There is a growing body of evidence regarding sociodemographic data, including the pervasive impact of medical racism on vaccine hesitancy, with additional studies on age, education, income, and more. Providers must serve as communicators and focus on presumptive language, strong recommendations, and tailored conversations with families who are hesitant about vaccines. [Pediatr Ann. 2025;54(5):e154–e159.]

Full text

Turn on search term navigation

Vaccines play a key role in disease prevention in children. The Centers for Disease Control and Prevention (CDC) estimates that among children born between 1994 and 2023, routine childhood vaccinations will have prevented approximately 508 million lifetime cases of illness, 32 million hospitalizations, and 1.129 million deaths, at a net savings of $540 billion in direct costs and $2.7 trillion in societal costs.1 Thus, vaccine hesitancy is a gripping topic affecting patients and their health outcomes due to concern for increased morbidity and mortality resulting from delayed or refused immunizations.

Vaccine hesitancy is defined by the World Health Organization (WHO) as the delay in acceptance or refusal of vaccines despite availability of vaccination services.2 In recent years, there has been increased recognition of vaccine hesitancy as a threat to public health, with hesitation rates varying greatly based on the specific vaccine, ranging from 56% for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine to 12% for other vaccines, such as polio.3 Specific vaccination rates and trends are influenced by multiple factors, including the SARS-CoV-2 pandemic, social media, equity, and social determinants. Headway has been made to identify key approaches to vaccine hesitancy in health care settings and beyond, although a paucity of literature remains about interventions in the examination room that impact vaccination rates. Ultimately, the WHO Immunization Agenda from 2021 outlined multiple goals to reach by 2030, including aiming for 90% coverage of essential vaccines in childhood and adolescence and a 50% reduction in the number of children missing out on all vaccines.4

The Impact of the SARS-CoV-2 Pandemic

In 2020, the SARS-CoV-2 pandemic struck the world, impacting everything from grocery store trips to immunization rates. There was a striking decrease in childhood immunizations during the pandemic, which was influenced by reduced access to health care services, an increased social media presence of antivaccine groups, and growing mistrust of medical organizations.5 When the vaccine against SARS-CoV-2 began distribution, discussions regarding vaccine development, safety, and efficacy were brought to the forefront of conversations.

Antivaccine sentiment that already existed prior to the pandemic had set the stage for worsening vaccine hesitancy. The movement aligned with right-wing politics for more targeted messaging, gained a strong online presence through forums and social media, and targeted medical professionals with harassment as part of an antiscience discourse.6 This ultimately combined to create an environment that antivaccine activists took advantage of by spreading discontent and doubt regarding vaccine trials, with data from UNICEF demonstrating declining confidence in childhood immunizations of up to 44 percentage points in some countries.7

A systematic review found confidence and complacency were key cognitive factors in those who refused the SARS-CoV-2 vaccination. Individuals who were likely to accept the vaccine had higher rates of confidence in government-based decisions, public health recommendations, and vaccine efficacy and delivery. Complacency focused on individuals who believed the disease was low-risk and unlikely to infect them, thus deeming the vaccine unnecessary.8 Furthermore, hesitancy during the SARS-CoV-2 pandemic was exacerbated by social media and the spread of misinformation. Conspiracy theories range from topics, such as technology-related theories (ie, microchips in the vaccine) to secret societies and power structures (ie, influence of Big Pharma).

There are multiple drivers of low SARS-CoV-2 update including low trust of various organizational bodies (ie, government vs health care organizations) coupled with both general and specific conspiracy theories. This introduced a new perspective on public health crises, arguing for the value of improved health communication in future pandemics. Rather than solely aiming interventions at increasing public knowledge, providers must also focus on rebuilding trust and consequently steering the public away from conspiracy theories.9

A Deeper Dive into the Vaccine-Specific Factors Influencing Vaccine Hesitancy

It is necessary to acknowledge that hesitancy is not equal among all vaccines (ie, the human papillomavirus [HPV] and influenza vaccines have high hesitancy rates). The Vaccine Hesitancy Scale, developed by the WHO, has been modified for the HPV and influenza vaccines, allowing for more relevant and accurate assessments of vaccine hesitancy.10

While we will be focusing on HPV and influenza vaccine hesitancy, it is important to note that the measles virus continues to cause more than 9 million cases of disease and 136,000 deaths worldwide every year.11 Disruptions to vaccination programs during the SARS-CoV-2 pandemic resulted in significant setbacks to administration efforts of the measles, mumps, rubella (MMR) vaccine, which have yet to be reversed. In communities where measles outbreaks have occurred, various concerns have been raised, such as adverse reactions, safety, total number of vaccines administered, and immunization schedules. Concerns about the association between MMR and autism spectrum disorder remain pervasive in these communities, despite evidence contrary to this claim.12

Human Papillomavirus Vaccine

The current recommendation from the Advisory Committee on Immunization Practices (ACIP) is for all genders to receive the 9-valent HPV vaccine series (ie, 2 or 3 doses based on age at initial vaccination) starting at age 11 years; although, administration can begin as early as age 9 years.13 Hesitancy toward the HPV immunization has been affected by its history and the sexually transmitted nature of the majority of HPV infections. Controversial political actions, media coverage, and changing recommendations all created confusion among parents and providers, reduced provider recommendations for the vaccination, and created feminization of the HPV vaccine. In the present day, some parents continue to believe there is no benefit to their male children.14 The current trend in HPV immunization rates demonstrates no significant changes from 2022 to 2023, with approximately 61% of teens fully vaccinated and 77% with at least 1 HPV vaccine.15

Parent and physician surveys have demonstrated an increase in physician recommendation to parents for the HPV vaccine since its release. Among hesitant parents, safety concerns increased in all demographic groups with the greatest increase among Black adolescent females. The most common reason for hesitancy varied by sex, race, and ethnicity, with “safety concerns” the highest for parents of White teenagers and “not necessary” the highest for parents of Black adolescent females.16

It is important to recognize that Black and Hispanic women are disproportionately affected by HPV infection and sequelae.17 In a 2023 study surveying 402 Black mothers, 48% of respondents indicated intention to vaccinate their daughters, thus demonstrating the importance of continuing targeted messaging and discussions between physicians and Black parents.17 The number of daughters, the HPV vaccine status of the mother, the perceived benefits and safety concerns of the HPV vaccine, pediatric HPV vaccination peer norms, and doctor recommendations were found to be independent factors of Black mothers' intentions to vaccinate their daughters against HPV.17

Furthermore, among young adults, immunization rates are higher in the LGBTQ+ (lesbian, gay, bisexual, trans-gender, queer or questioning, intersex, asexual) community, which is important to acknowledge given the increased risk of HPV-related cancers in sexual and gender minority groups.18 Pediatricians should continue to be aware of trends in the communities they serve to promote data-driven knowledge about the HPV vaccine.

Influenza Vaccine

The ACIP recommends that all children age 6 months and older receive the influenza vaccine annually. Influenza is highly transmissible and adds a great burden to the US health care system, with approximately $3 billion in direct medical costs and $8 billion in indirect medical costs, such as loss of productivity every year.19 Importantly, racial-ethnic minority groups disproportionately experience adverse flu-related outcomes, with severe outcomes (eg, hospitalization, intensive care admission, death) up to 4 times higher compared with White individuals.20

Influenza vaccination rates have been steadily decreasing since the SARS-CoV-2 pandemic, now down 8 percentage points compared with the pre–SARS-CoV-2 pandemic influenza season. During the 2023–2024 season, only 55.4% of children were vaccinated against influenza.21 In 2023, at least 30% of children had a parent who was hesitant about the influenza vaccine.21

The influenza vaccine is susceptible to increased vaccine hesitancy because it is required annually, is less effective against symptomatic disease compared with other immunizations, and is subject to false beliefs (eg, “the vaccine causes the virus”).22 Studies have demonstrated that providers have the capacity to influence parental intent to vaccinate. Motivational interviewing, use of presumptive language, bundling the influenza vaccine with other shots, and having multiple conversations despite initial parental hesitation has been shown to increase acceptance rates.23 Thus, ongoing discussions among families, particularly those in populations that are more likely to be hesitant, and education for the general public are essential to decrease influenza vaccine hesitancy.

The Spreading Influence of Social Media

Despite decades of immunization safety data, concerns about vaccine safety remain. Vaccine hesitancy has been directly linked to misinformation being spread on social media.24 Studies on social media range from focusing on a single vaccine, on specific vaccination campaigns, or using artificial intelligence to study trends in language. Additionally, health care professionals have started to use social media, various applications, and virtual reality to study and improve vaccination rates in their communities.25–27

Given the scale of antivaccine sentiment on social media that is difficult to counter with face-to-face interactions alone, Wolynn et al.25 created an action-oriented support tool to help health care providers become more adept at leveraging social media. Their goal is to amplify pediatricians' voices to effectively reach patients and their families as part of the solution to decrease vaccine misinformation. The ADEPT (amplify, direct, engage, post, tag) toolbox describes the importance of amplifying trusted voices (eg, CDC, American Academy of Pediatrics [AAP]), directing patients to information resources about vaccine clinics and reputable online vaccine safety (eg, Vaccine Safety Net [https://www.vaccinesafetynet.org/#gsc.tab=0]), engaging with empathy when speaking with families about vaccines, and posting and tagging new content.25

Ruggeri et al.28 compiled a list of evidence-based insights that can help health care providers confront vaccine hesitancy on social media. They highlight the importance of creating targeted messages that address both parents and adolescents. Messages must be high-quality, visible, and incorporate cultural values.28 Lastly—and possibly most importantly—messaging from a trusted source is likely to have a major role in vaccination decisions. Such advocacy through social media may leave health care providers vulnerable to attack from online anti-vaccine groups. Organizations, such as Shots Heard Round the World (https://shotsheard.org/), support providers advocating for vaccination on social media that might encounter threats.

Socioeconomic Factors Related to Vaccine Hesitancy

Vaccination uptake is influenced by both behavioral and social drivers. Barriers to vaccination can be structural (eg, access) and attitudinal (eg, beliefs, perceptions). These structural and attitudinal barriers are subject to fluctuation over time and across population subgroups. Beliefs and perceptions may be informed by historical injustices, trust or mistrust in health care systems, and misinformation.29

Racial discrimination has been directly correlated with increased odds of vaccine hesitancy.30 Padamsee et al.31 explore how medical racism likely affected these trends, causing caution among the Black community in newly introduced medical technologies. However, this vaccine hesitancy was shown to be more easily overcome than that of White individuals.31 Age, sexual orientation, income, education, employment, and health insurance status have also been studied as they relate to vaccination decisions. Findings vary depending on the specific vaccine and the study environment, among other factors.32–34

Ultimately, health care providers and community leaders should focus on susceptibility, severity of infection, benefits of vaccination, safety concerns, and vaccine efficacy. Understanding the unique needs of your specific community will allow providers and policy makers to help address the underlying causes of low uptake, including lack of confidence in vaccines and health care/government services, as well as issues related to access.35

The Pediatrician's Approach to Vaccine Hesitancy

While there are multiple approaches to the family who is hesitant about vaccines, we have compiled alternatives from recent research to provide a starting point for pediatricians and key objectives for educating the future pediatric workforce. First, it is important to note that parents may have skepticism or hesitation but still ultimately be willing to vaccinate their children. The AAP and CDC recommend similar approaches to vaccination, starting with using presumptive language with parents. This sets the default as vaccination and has been shown to increase vaccination uptake.36

Both organizations address the need for providers to give strong recommendations for the vaccines in question, clearly citing why the vaccine is recommended by the medical field and tailoring it with personal additions. Active listening is key to tailor conversations based on parental concerns. Most parents act out of concern and protection of their children, and it is essential to approach vaccination conversations with that in mind. Asking parents specific questions to adapt the dialogue to their hesitations opens the ground for increased trust of providers. These recommendations are summarized in Figure 1.37,38 Yashar-Gershman et al.39 are developing and evaluating a novel process of quickly identifying parental mindsets at point-of-care in order to tailor provider messaging in addressing specific parent/caregiver concerns.

Figure 1. - The pediatrician's approach to vaccine hesitancy. Adapted from Centers for Disease Control and Prevention38 and Yashar-Gershman et al.39

Beyond these key approaches to the vaccine conversations, providers must consider the changing landscape of medical decisions among patients (eg, the rise of conspiracy theories) and must leverage technology for solutions. When myths arise, Limaye et al.40 recommend pivoting the conversation to focus instead on the disease process rather than directly countering misconceptions that may actually reinforce incorrect information. Given safety concerns expressed by parental surveys, providers benefit from understanding the vaccine surveillance system (eg, Vaccine Safety Datalink, Vaccine Adverse Events Reporting System) to help be prepared to address parental concerns.37

Conclusion

Vaccine hesitancy is an ongoing public health concern. It has been greatly influenced by the SARS-CoV-2 pandemic and the rise of antivaccine messaging on social media. Hesitancy is often vaccine-specific, with varying rates of parental hesitancy regarding immunizations to prevent SARS-CoV-2, influenza, HPV, and other childhood diseases. As physicians continue to explore this topic with patients, it is necessary to understand potential sociodemographic factors at play, use presumptive language, give strong recommendations, and apply active listening skills to discuss vaccination concerns.

1. Zhou F, Jatlaoui TC, Leidner AJ,. Health and economic benefits of routine childhood immunizations in the era of the vaccines for children program- United States, 1994–2023. MMWR Morb Mortal Wkly Rep. 2024;73(31): 682–685. 10.15585/mmwr.mm7331a2 PMID: 39116024

2. Vaccine hesitancy:agrowing challenge for immunization programmes. World Health Organization. Published August 18, 2015. Accessed March 12, 2025. https://www.who.int/news/item/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes

3. Santibanez TA, Black CL, Zhou T, Srivastav A, Singleton JA. Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines. Vaccine. 2024;42(25): 126139. 10.1016/j.vaccine.2024.07.040 PMID: 39019662

4. Explaining the Immunization Agenda 2030. World Health Organization. Accessed March 12, 2025. https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030/explaining-the-immunization-agenda-2030

5. Lv SR, Wang MK, Yu XL, Li XY, Yang JS. Impact of COVID-19 pandemic on routine childhood vaccinations. WorldJVirol. 2024;13(2): 90271. 10.5501/wjv.v13.i2.90271 PMID: 38984085

6. Carpiano RM, Callaghan T, DiResta R,. Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. Lancet. 2023;401(10380): 967–970. 10.1016/S0140-6736(23)00136-8 PMID: 36871571

7. New data indicates declining confidence in childhood vaccines of up to 44 percentage points in some countries during the COVID-19 pandemic. UNICEF. Published April 20, 2023. Accessed March 12, 2025. https://www.unicef.org/press-releases/sowc_2023_immunization

8. Pourrazavi S, Fathifar Z, Sharma M, Allah-verdipour H. COVID-19 vaccine hesitancy:asystematic review of cognitive determinants. Health Promot Perspect. 2023;13(1): 21–35. 10.34172/hpp.2023.03 PMID: 37309435

9. Andrews EA, Walter N, Ophir Y, Walter D, Robbins CL. Vaccine hesitancy and its epistemic antecedents:ameta-analysis. Health Commun. 2024:1–12. 10.1080/10410236.2024.2431165

10. Helmkamp LJ, Szilagyi PG, Zimet G,.Avalidated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines. Vaccine. 2021;39(13): 1831–1839. 10.1016/j.vaccine.2021.02.039 PMID: 33676784

11. Minta AA, Ferrari M, Antoni S,. Progress toward measles elimination- worldwide, 2000–2022. MMWR Morb Mortal Wkly Rep. 2023;72(46): 1262–1268. 10.15585/mmwr.mm7246a3 PMID: 37971951

12. Novilla MLB, Goates MC, Redelfs AH,. Why parents say no to having their children vaccinated against measles:asystematic review of the social determinants of parental perceptions on MMR vaccine hesitancy. Vaccines(Basel). 2023;11(5): 926. 10.3390/vaccines11050926 PMID: 37243030

13. Advisory Committee on Immunization Practices. ACIP vaccine recommendations and guidelines. ACIP recommendations: human papillomavirus(HPV) vaccine. Updated July 29, 2024. Accessed March 12, 2025. https://www.cdc.gov/acip-recs/hcp/vaccine-specific/hpv.html

14. Morales-Campos DY, Zimet GD, Kahn JA. Human papillomavirus vaccine hesitancy in the United States. Pediatr Clin North Am. 2023;70(2): 211–226. 10.1016/j.pcl.2022.11.002 PMID: 36841591

15. Pingali C, Yankey D, Chen M,. National vaccination coverage among adolescents aged 13–17 years- national immunization survey-teen, United States, 2023. MMWR Morb Mortal Wkly Rep. 2024;73(33): 708–714. 10.15585/mmwr.mm7333a1 PMID: 39173168

16. White JL, Grabowski MK, Rositch AF,. Trends in adolescent human papillomavirus vaccination and parental hesitancy in the United States.JInfect Dis. 2023;228(5): 615–626. 10.1093/infdis/jiad055 PMID: 36869689

17. Gray A, Fisher CB. Factors associated with HPV vaccine acceptability and hesitancy among Black mothers with young daughters in the United States. Front Public Health. 2023;11:1124206. 10.3389/fpubh.2023.1124206 PMID: 37139381

18. Sonawane K, Garg A, Meissner EG,. Human papillomavirus vaccination among young adults before and during the COVID-19 pandemic. JAMA Netw Open. 2024;7(2): e2356875. 10.1001/jamanetworkopen.2023.56875

19. Putri WCWS, Muscatello DJ, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27): 3960–3966. 10.1016/j.vaccine.2018.05.057 PMID: 29801998

20. O'Halloran AC, Holstein R, Cummings C,. Rates of influenza-associated hospitalization, intensive care unit admission, and in-hospital death by race and ethnicity in the United States from 2009 to 2019. JAMA Netw Open. 2021;4(8): e2121880. 10.1001/jamanetworkopen.2021.21880 PMID: 34427679

21. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2023–24 influenza season. FluVaxView. Accessed April 14, 2025. https://www.cdc.gov/fluvaxview/coverage-by-season/2023-2024.html

22. Kumar S, Shah Z, Garfield S. Causes of vaccine hesitancy in adults for the influenza and COVID-19 vaccines:asystematic literature review. Vaccines(Basel). 2022;10(9): 1518. 10.3390/vaccines10091518 PMID: 36146596

23. Stephens AB, Hofstetter AM, Stockwell MS. Influenza vaccine hesitancy: scope, influencing factors, and strategic interventions. Pediatr Clin North Am. 2023;70(2): 227–241. 10.1016/j.pcl.2022.11.003 PMID: 36841592

24. Burki T. Vaccine misinformation and social media. Lancet. 2019;1(6): E258–E259. https://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30136-0/fulltext

25. Wolynn T, Hermann C, Hoffman BL. Social media and vaccine hesitancy: help us move the needle. Pediatr Clin North Am. 2023;70(2): 329–341. 10.1016/j.pcl.2022.11.010 PMID: 36841600

26. Bishop JM, Real FJ, McDonald SL,. Evaluation of HPV vaccine: Same Way, Same Day TM:a pilot study.JHealth Commun. 2021;26(12): 839–845. 10.1080/10810730.2021.2021459 PMID: 34985403

27. Vandeweerdt C, Luong T, Atchapero M,. Virtual reality reduces COVID-19 vaccine hesitancy in the wild:arandomized trial. Sci Rep. 2022;12(1): 4593. 10.1038/s41598-022-08120-4 PMID: 35301359

28. Ruggeri K, Vanderslott S, Yamada Y,. Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media. BMJ. 2024;384:e076542. 10.1136/bmj-2023-076542 PMID: 38228339

29. Majekodunmi P, Tulli-Shah M, Kemei J, Kayode I, Maduforo AN, Salami B. Interventions employed to address vaccine hesitancy among Black populations outside of African and Caribbean countries:ascoping review. BMC Public Health. 2024;24(1): 3147. 10.1186/s12889-024-20641-3 PMID: 39538186

30. CarlLee S, Willis DE, Andersen JA,. Healthcare access and experiences of racial discrimination as predictors of general vaccine hesitancy. Vaccines(Basel). 2023;11(2): 409. 10.3390/vaccines11020409 PMID: 36851286

31. Padamsee TJ, Bond RM, Dixon GN,. Changes in COVID-19 vaccine hesitancy among Black and White individuals in the US. JAMA Netw Open. 2022;5(1): e2144470. 10.1001/jamanet-workopen.2021.44470 PMID: 35061038

32. Zhang X, Monnat SM. Watchful, skeptics, and system distrusters: characteristics associated with different types of COVID-19 vaccine hesitancy among U.S. working-age adults. Vaccine. 2024;42(24): 126080. 10.1016/j.vaccine.2024.06.047 PMID: 38902188

33. Sonawane K, Zhu Y, Damgacioglu H,. Factors associated with parental human papillomavirus vaccination intentions among adolescents from socioeconomically advantaged versus deprived households:anationwide, cross-sectional survey. Lancet Reg Health Am. 2024;31(100694): 100694. 10.1016/j.lana.2024.100694 PMID: 38500960

34. Adzrago D, Ormiston CK, Sulley S, Williams F. Associations between the self-reported likelihood of receiving the COVID-19 vaccine, likelihood of contracting COVID-19, discrimination, and anxiety/depression by sexual orientation. Vaccines(Basel). 2023;11(3): 582. 10.3390/vaccines11030582 PMID: 36992166

35. Khan MS, Ali SAM, Adelaine A, Karan A. Rethinking vaccine hesitancy among minority groups. Lancet. 2021;397(10288): 1863–1865. 10.1016/S0140-6736(21)00938-7 PMID: 33894143

36. Opel DJ, Zhou C, Robinson JD,. Impact of childhood vaccine discussion format over time on immunization status. Acad Pediatr. 2018;18(4): 430–436. 10.1016/j.acap.2017.12.009 PMID: 29325912

37. O'Leary ST, Opel DJ, Cataldi JR, Hackell JM;Committee on Infectious Diseases;Committee on Practice and Ambulatory Medicine;Committee on Bioethics. Strategies for improving vaccine communication and up-take. Pediatrics. 2024;153(3): e2023065483. 10.1542/peds.2023-065483

38. Centers for Disease Control and Prevention. Vaccines for your children: talking with parents about vaccines. Updated August 9, 2024. Accessed March 12, 2025. https://www.cdc.gov/vaccines-children/hcp/conversation-tips/index.html

39. Yashar-Gershman SG, Rosenberg AT, Sawhney M, Fernanda Machicao M, Moskowitz HR, Bernstein HH. Developinganovel screening tool to address pediatric COVID-19 vaccine hesitancy at point of care. Vaccine. 2024;42(9): 2260–2270. 10.1016/j.vaccine.2024.02.069 PMID: 38431443

40. Limaye RJ, Opel DJ, Dempsey A,. Communicating with vaccine-hesitant parents:anarrative review. Acad Pediatr. 2021;21(4S): S24–S29. 10.1016/j.acap.2021.01.018 PMID: 33958087

From University of Colorado School of Medicine, Aurora, Colorado.

Disclosure: The authors have disclosed no potential conflicts of interest, financial or otherwise.

Copyright 2025, SLACK Incorporated